Myricanone
CAS: 32492-74-3
Ref. 3D-HBA49274
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one
- Tricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-
- Tricyclo[12.3.1.1~2,6~]Nonadeca-1(18),2,4,6(19),14,16-Hexaen-9-One, 3,15-Dihydroxy-16,17-Dimethoxy-
Myricanone is a synthetic curcumin analog that is used to treat bowel disease, skin cancer, and other conditions. It has been shown to inhibit protein target nitro (PTN), a key enzyme in the synthesis of proteins involved in inflammation and cancer. Myricanone also inhibits the growth of cancer cells by inhibiting their ability to divide and proliferate. Myricanone has been found to have anti-inflammatory effects, which may be due to its inhibition of cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2). Myricanone has also been shown to have sodium-dependent glucose cotransporter 1 (SGLT1) activity. The compound causes mitochondrial membrane depolarization by inhibiting complex I of the electron transport chain.
Propriedades químicas
Consulta técnica sobre: 3D-HBA49274 Myricanone
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
